High-risk cases according to the MMP14 co-scoring system, including the total MMP14 enzymatic activity derived from tumour nest and CAFs, were associated with ENE+; 83% of them had ENE+ (p < 0.05). The gene discussed is MMP14; the disease is neoplasm.